まとめ
IHSSに対する手術は,長期的な症状の改善と減少したアウトフローグラデーションを提供します. しかし,一部の患者は,高縮性心筋病変症による持続的な制限や遅い死亡を経験します.
科学分野:
- 心臓病学 心臓病学
- 心臓外科手術について
背景:
- ハイパートロフィック阻害性心筋症 (IHSS) は複雑な疾患である.
- IHSSの管理には外科介入が用いられているが,長期的な結果は徹底的な評価が必要である.
研究 の 目的:
- IHSSのための外科介入の長期的な結果をレビューする.
- IHSSのために手術を受ける患者の症状改善,血液動力学的変化,および長期的な生存率を評価する.
主な方法:
- 1960年から1975年の間にIHSSのために手術を受けた124人の患者の遡及的レビュー.
- 症状状態の分析,左心室 (LV) 流出梯度,およびフォローアップ中の死亡原因.
主要な成果:
- ほとんどの患者 (88%) は,症状の改善と術後のLV流出グラデントの減少を経験しました.
- しかし,8%は手術前死亡,12%は機能的限界が持続し,9%は心筋縮性心筋病症のために遅れて死亡しました.
- 年間総死亡率は3.5%で,遅い死亡は年間1.8%を占め,多くの場合,心房細動およびその他の併発性疾患に関連しています.
結論:
- 長期的な臨床改善は,IHSS手術を生き残ったほとんどの患者で達成可能である.
- 重要な少数派は持続的な制限や遅い死亡に直面しており,高縮性心筋症の継続的なモニタリングと管理の必要性を強調しています.
- 継続的な年間死亡率の低さは,この病気の慢性的な性質と,手術が成功しても起こりうる合併症を強調しています.
関連する概念動画
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Aortic Regurgitation I: Introduction
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...


